Entity

Time filter

Source Type

Vishākhapatnam, India

Rambabu A.,Acharya Nagarjuna University | Kumari K.J.,Acharya Nagarjuna University | Baby Ramana M.,Acharya Nagarjuna University | Ramani M.V.,Natsol Laboratories Private Ltd | And 2 more authors.
Asian Journal of Chemistry | Year: 2016

Apigenin and luteolin are the antioxidant flavonoids found in foods such as parsley, artichoke, basil and celery. Both of these compounds have shown the ability to protect cells against cancer and also to inhibit DNA oxidative damage. These flavonoids are part of many nutraceutical formulations available in the market. There is a need for the development of cost effective methodologies to produce them in large quantities. The synthetic process developed for both these compounds is general and can be applied for other flavonoids also. An industrially applicable high pure product, cost effective synthesis and general synthetic method has been developed and presented. Source


Trademark
Natsol Laboratories Private Ltd | Date: 2011-11-18

Dietetic food or beverages adapted for medical use containing flavonols, dietary supplements containing flavonols.


Balaji N.V.,Natsol Laboratories Private Ltd | Ramani M.V.,Natsol Laboratories Private Ltd | Viana A.G.,Tuskegee University | Sanglard L.P.,Tuskegee University | And 8 more authors.
Bioorganic and Medicinal Chemistry | Year: 2015

Phytochemicals play an important role in cancer therapy. Hispolon and 26 of its analogs (9 known and 17 new) were synthesized and evaluated for their antiproliferative activities in a panel of six independent human cancer cell lines using the in vitro cell-based MTT assay. Among the hispolon analogs tested, compound VA-2, the most potent overall, produced its most significant effect in the colon cancer cell lines HCT-116 (IC50 1.4 ± 1.3 μM) and S1 (IC50 1.8 ± 0.9 μM) compared to its activity in the normal HEK293/pcDNA3.1 cell line (IC50 15.8 ± 3.7 μM; p <0.01 for each comparison). Based on our results, VA-2 was about 9- to 11-times more potent in colon cancer cells and 2- to 3-times more potent in prostate cancer cells compared to HEK293/pcDNA3.1 cells. Morphological analysis of VA-2 showed significant reduction of cell number, while the cells' sizes were also markedly increased and were obvious at 68 h of treatment with 1 μM in HCT-116 (colon) and PC-3 (prostate) cancer cells. A known analog, compound VA-4, prepared by simple modifications on the aromatic functional groups of hispolon, inhibited prostate and colon cancer cell lines with IC50 values <10 μM. In addition, hispolon isoxazole and pyrazole analogs, VA-7 and VA-15 (known), respectively, have shown significant activity with the mean IC50 values in the range 3.3-10.7 μM in all the cancer cell lines tested. Activity varied among the analogs in which aromatic functional groups and β-diketone functional groups are modified. But the activity of analogs VA-16 to VA-27 was completely lost when the side chain double-bond was hydrogenated indicating the crucial role of this functionality for anticancer activity. Furthermore, many of the compounds synthesized were not substrates for the ABCB1-transporter, the most common cause of multidrug resistance in anti-cancer drugs, suggesting they may be more effective anticancer agents. ©2015 Elsevier Ltd. All rights reserved. Source

Discover hidden collaborations